Search hospitals > Pennsylvania > Bryn Mawr

Bryn Mawr Hospital

Claim this profile
Bryn Mawr, Pennsylvania 19010
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
249 reported clinical trials
6 medical researchers
Photo of Bryn Mawr Hospital in Bryn MawrPhoto of Bryn Mawr Hospital in Bryn MawrPhoto of Bryn Mawr Hospital in Bryn Mawr

Summary

Bryn Mawr Hospital is a medical facility located in Bryn Mawr, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Bryn Mawr Hospital is involved with conducting 249 clinical trials across 254 conditions. There are 6 research doctors associated with this hospital, such as Albert DeNittis, MD, Paul B. Gilman, Deric C. Savior, and John G. Devlin.

Area of expertise

1Cancer
Global Leader
Bryn Mawr Hospital has run 80 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Bryn Mawr Hospital has run 53 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
HER2 positive

Top PIs

Clinical Trials running at Bryn Mawr Hospital

Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Ovarian Cancer
Fallopian Tube Cancer
Follicular Lymphoma
Squamous Cell Carcinoma
Esophageal Adenocarcinoma
Gastric Cancer
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Bryn Mawr Hospital?
Bryn Mawr Hospital is a medical facility located in Bryn Mawr, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Bryn Mawr Hospital is involved with conducting 249 clinical trials across 254 conditions. There are 6 research doctors associated with this hospital, such as Albert DeNittis, MD, Paul B. Gilman, Deric C. Savior, and John G. Devlin.